MAGED1: Molecular insights and clinical implications

References

• van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, . A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254:1643–7.
   PubMed Web of Science ®Google Scholar
• Goldman B, DeFrancesco L. The cancer vaccine roller coaster. Nat Biotechnol. 2009;27:129–39.
   PubMed Web of Science ®Google Scholar
• Brichard VG, Lejeune D. GSK's antigen-specific cancer immunotherapy programme: pilot results leading to phase III clinical development. Vaccine. 2007;25 Suppl 2:B61–71.
   PubMedGoogle Scholar
• Francois V, Ottaviani S, Renkvist N, Stockis J, Schuler G, Thielemans K, . The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells. Cancer Res. 2009;69:4335–45.
   PubMed Web of Science ®Google Scholar
• Yang B, O’Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, . MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res. 2007;67: 9954–62.
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng S, Asa SL, Ezzat S. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res. 2008 ;68:8104–12.
   PubMed Web of Science ®Google Scholar
• Marcar L, Maclaine NJ, Hupp TR, Meek DW. Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res. 2010;70:10362–70.
   PubMedGoogle Scholar
• Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010;39:963–74.
   PubMed Web of Science ®Google Scholar
• Masuda Y, Sasaki A, Shibuya H, Ueno N, Ikeda K, Watanabe K. Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J Biol Chem. 2001;276:5331–8.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem. 2002; 277:22541–6.
   PubMedGoogle Scholar
• Wang X, Tang J, Xing L, Shi G, Ruan H, Gu X, . Interaction of MAGED1 with nuclear receptors affects circadian clock function. EMBO J. 2010;29:1389–400.
   PubMedGoogle Scholar
• Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, . NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron. 2000;27:279–88.
   PubMed Web of Science ®Google Scholar
• Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol. 2002;67:203–33.
   PubMed Web of Science ®Google Scholar
• Salehi AH, Xanthoudakis S, Barker PA. NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem. 2002;277:48043–50.
   PubMed Web of Science ®Google Scholar
• Williams ME, Strickland P, Watanabe K, Hinck L. UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE. J Biol Chem. 2003;278:17483–90.
   PubMed Web of Science ®Google Scholar
• Bradford D, Cole SJ, Cooper HM. Netrin-1: diversity in development. Int J Biochem Cell Biol. 2009;41:487–93.
   PubMed Web of Science ®Google Scholar
• Hedgecock EM, Culotti JG, Hall DH. The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans. Neuron. 1990;4:61–85.
   PubMed Web of Science ®Google Scholar
• Leung-Hagesteijn C, Spence AM, Stern BD, Zhou Y, Su MW, Hedgecock EM, . UNC-5, a transmembrane protein with immunoglobulin and thrombospondin type 1 domains, guides cell and pioneer axon migrations in C. elegans. Cell. 1992;71:289–99.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Hinck L, Watanabe K. RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins. J Recept Signal Transduct Res. 2005;25:181–98.
   PubMed Web of Science ®Google Scholar
• Parkhurst CN, Zampieri N, Chao MV. Nuclear localization of the p75 neurotrophin receptor intracellular domain. J Biol Chem. 2010;285:5361–8.
   PubMedGoogle Scholar
• Kendall SE, Battelli C, Irwin S, Mitchell JG, Glackin CA, Verdi JM. NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol. 2005;25:7711–24.
   PubMed Web of Science ®Google Scholar
• Wen CJ, Xue B, Qin WX, Yu M, Zhang MY, Zhao DH, . hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation. FEBS Lett. 2004; 564:171–6.
   PubMed Web of Science ®Google Scholar
• Tian XX, Rai D, Li J, Zou C, Bai Y, Wazer D, . BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res. 2005;65:4747–53.
   PubMedGoogle Scholar
• Monte M, Simonatto M, Peche LY, Bublik DR, Gobessi S, Pierotti MA, . MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci USA. 2006;103:11160–5.
   PubMed Web of Science ®Google Scholar
• Sepp KJ, Hong P, Lizarraga SB, Liu JS, Mejia LA, Walsh CA, . Identification of neural outgrowth genes using genome-wide RNAi. PLoS Genet. 2008;4:e1000111.
   Google Scholar
• Nishimura I, Shimizu S, Sakoda JY, Yoshikawa K. Expression of Drosophila MAGE gene encoding a necdin homologous protein in postembryonic neurogenesis. Gene Expr Patterns. 2007;7:244–51.
   PubMedGoogle Scholar
• Nishimura I, Sakoda JY, Yoshikawa K. Drosophila MAGE controls neural precursor proliferation in postembryonic neurogenesis. Neuroscience. 2008;154:572–81.
   PubMedGoogle Scholar
• Isabel G, Pascual A, Preat T. Exclusive consolidated memory phases in Drosophila. Science. 2004;304:1024–7.
   PubMed Web of Science ®Google Scholar
• Davis RL. Olfactory memory formation in Drosophila: from molecular to systems neuroscience. Annu Rev Neurosci. 2005;28:275–302.
   PubMed Web of Science ®Google Scholar
• Igaki T, Kanda H, Yamamoto-Goto Y, Kanuka H, Kuranaga E, Aigaki T, . Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO J. 2002;21: 3009–18.
   PubMed Web of Science ®Google Scholar
• Moreno E, Yan M, Basler K. Evolution of TNF signaling mechanisms: JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily. Curr Biol. 2002;12:1263–8.
   PubMed Web of Science ®Google Scholar
• Kanda H, Igaki T, Kanuka H, Yagi T, Miura M. Wengen, a member of the Drosophila tumor necrosis factor receptor superfamily, is required for Eiger signaling. J Biol Chem. 2002;277:28372–5.
   PubMed Web of Science ®Google Scholar
• Kauppila S, Maaty WS, Chen P, Tomar RS, Eby MT, Chapo J, . Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene. 2003;22:4860–7.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789–91.
   PubMed Web of Science ®Google Scholar
• Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann Med. 2008;40:562–83.
   PubMed Web of Science ®Google Scholar
• Fujii T, Kunugi H. p75NTR as a therapeutic target for neuropsychiatric diseases. Curr Mol Pharmacol. 2009;2: 70–6.
   PubMedGoogle Scholar
• Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, . Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest. 1997;100:2333–40.
   PubMed Web of Science ®Google Scholar
• Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci. 2008;28:3941–6.
   PubMed Web of Science ®Google Scholar
• Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science. 2001;294:1945–8.
   PubMed Web of Science ®Google Scholar
• Peng S, Wuu J, Mufson EJ, Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol. 2004;63:641–9.
   PubMed Web of Science ®Google Scholar
• Pedraza CE, Podlesniy P, Vidal N, Arevalo JC, Lee R, Hempstead B, . Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol. 2005;166:533–43.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102: 15545–50.
   PubMed Web of Science ®Google Scholar
• Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA. 2004;101:2173–8.
   PubMed Web of Science ®Google Scholar
• Reddy EM, Chettiar ST, Kaur N, Ganeshkumar R, Shepal V, Shanbhag NC, . Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells. Cancer Gene Ther. 2011;18:206–18.
   PubMedGoogle Scholar
• Berenjeno IM, Nunez F, Bustelo XR. Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases. Oncogene. 2007;26:4295–305.
   PubMed Web of Science ®Google Scholar
• Chiaradonna F, Sacco E, Manzoni R, Giorgio M, Vanoni M, Alberghina L. Ras-dependent carbon metabolism and transformation in mouse fibroblasts. Oncogene. 2006;25: 5391–404.
   PubMed Web of Science ®Google Scholar
• Boylan KL, Gosse MA, Staggs SE, Janz S, Grindle S, Kansas GS, . A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma. Cancer Res. 2007;67:4069–78.
   PubMed Web of Science ®Google Scholar
• Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, . Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008;68:6779–88.
   PubMed Web of Science ®Google Scholar
• Chung FY, Cheng TL, Chang HJ, Chiu HH, Huang MY, Chang MS, . Differential gene expression profile of MAGE family in taiwanese patients with colorectal cancer. J Surg Oncol. 2010;102:148–53.
   PubMedGoogle Scholar
• Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, . Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24:305–12.
   PubMed Web of Science ®Google Scholar
• Ringwald M, Iyer V, Mason JC, Stone KR, Tadepally HD, Kadin JA, . The IKMC web portal: a central point of entry to data and resources from the International Knockout Mouse Consortium. Nucleic Acids Res. 2011;39(Database issue):D849–55.
   Google Scholar
• Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, . The knockout mouse project. Nat Genet. 2004;36:921–4.
   PubMed Web of Science ®Google Scholar
• Ptitsyn AA, Zvonic S, Conrad SA, Scott LK, Mynatt RL, Gimble JM. Circadian clocks are resounding in peripheral tissues. PLoS Comput Biol. 2006;2:e16.
   PubMed Web of Science ®Google Scholar
• Ueda HR, Chen W, Adachi A, Wakamatsu H, Hayashi S, Takasugi T, . A transcription factor response element for gene expression during circadian night. Nature. 2002; 418:534–9.
   PubMed Web of Science ®Google Scholar
• Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, . Mop3 is an essential component of the master circadian pacemaker in mammals. Cell. 2000;103:1009–17.
   PubMed Web of Science ®Google Scholar
• Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302:255–9.
   PubMed Web of Science ®Google Scholar
• Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, . Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005;308:1043–5.
   PubMed Web of Science ®Google Scholar
• Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science. 2009;324:654–7.
   PubMed Web of Science ®Google Scholar
• Herzog ED. Neurons and networks in daily rhythms. Nat Rev Neurosci. 2007;8:790–802.
   PubMed Web of Science ®Google Scholar
• Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, . Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell. 2001;105:683–94.
   PubMed Web of Science ®Google Scholar
• Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, . mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999;98:193–205.
   PubMed Web of Science ®Google Scholar
• van der Horst GT, Muijtjens M, Kobayashi K, Takano R, Kanno S, Takao M, . Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature. 1999;398:627–30.
   PubMed Web of Science ®Google Scholar
• Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, . The orphan nuclear receptor REV-ER Balpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 2002;110: 251–60.
   PubMed Web of Science ®Google Scholar
• Ueda HR, Hayashi S, Chen W, Sano M, Machida M, Shigeyoshi Y, . System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet. 2005;37:187–92.
   PubMed Web of Science ®Google Scholar
• Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, . Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science. 2009;324: 651–4.
   PubMed Web of Science ®Google Scholar
• Albrecht U, Eichele G. The mammalian circadian clock. Curr Opin Genet Dev. 2003;13:271–7.
   PubMed Web of Science ®Google Scholar
• Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, . A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 2004;43:527–37.
   PubMed Web of Science ®Google Scholar
• Naylor E, Bergmann BM, Krauski K, Zee PC, Takahashi JS, Vitaterna MH, . The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci. 2000; 20:8138–43.
   PubMed Web of Science ®Google Scholar
• Laposky A, Easton A, Dugovic C, Walisser J, Bradfield C, Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep. 2005;28:395–409.
   PubMed Web of Science ®Google Scholar
• Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, . An hPer2 phosphorylation site mutation infamilial advanced sleep phase syndrome. Science. 2001;291: 1040–3.
   PubMed Web of Science ®Google Scholar
• Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, . Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 2005;434:640–4.
   PubMed Web of Science ®Google Scholar
• Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptacek LJ. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell. 2007;128:59–70.
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Isacson O, O’Brien TS. Nerve growth factor receptor immunoreactivity in the rat suprachiasmatic nucleus. Brain Res. 1989;476:358–62.
   PubMed Web of Science ®Google Scholar
• Kiss J, Patel AJ, Halasz B. Colocalization of NGF receptor with VIP in rat suprachiasmatic neurones. Neuroreport. 1993;4:1315–8.
   PubMed Web of Science ®Google Scholar
• Bina KG, Rusak B. Nerve growth factor phase shifts circadian activity rhythms in Syrian hamsters. Neurosci Lett. 1996;206:97–100.
   PubMed Web of Science ®Google Scholar
• Liang FQ, Allen G, Earnest D. Role of brain-derived neurotrophic factor in the circadian regulation of the suprachiasmatic pacemaker by light. J Neurosci. 2000;20:2978–87.
   PubMed Web of Science ®Google Scholar
• Akashi M, Takumi T. The orphan nuclear receptor ROR[alpha] regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol. 2005;12: 441–8.
   PubMed Web of Science ®Google Scholar
• Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, . Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet. 2009; 373:482–91.
   PubMed Web of Science ®Google Scholar
• Waterhouse J, Reilly T, Atkinson G, Edwards B. Jet lag: trends and coping strategies. Lancet. 2007;369:1117–29.
   PubMed Web of Science ®Google Scholar
• Meng QJ, Maywood ES, Bechtold DA, Lu WQ, Li J, Gibbs JE, . Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc Natl Acad Sci USA. 2010;107:15240–5.
   PubMed Web of Science ®Google Scholar